“Reverses aging” is too broad to evaluate until the claim names an outcome. Does it mean a changed blood test, improved function, fewer illnesses or longer life? Those findings would require different studies.
The product also needs a name. Peptides are short amino-acid chains, not a single intervention with one predictable effect.[1]
Separate a measured change from its interpretation
A blood test measures something specific. Interpreting that result requires its purpose, reference range and the person’s broader health context. MedlinePlus notes that an out-of-range value can occur in a healthy person, while an in-range result does not necessarily mean good health.[2]
If a longevity claim rests on a laboratory change, the next question is whether the research actually measured a health benefit. A number moving in the intended direction and a person living longer are different observations.
Read the study’s purpose
FDA describes early clinical trials as investigations of safety, how a drug behaves in the body and appropriate dosing. Later trials are designed to test treatment benefits in a defined population. Study size and duration also affect which adverse effects can be detected.[3]
A small, short-term study can therefore provide useful early information without answering a lifespan question. The relevant details are who participated, what they received, what was compared, what changed and how long follow-up lasted.[3]
Check what “approved” refers to
An approved medicine has been evaluated for the uses in its labeling. A new claim outside those uses does not inherit FDA’s finding of safety and effectiveness.[4]
For any proposed longevity product, a credible account should finish the sentence precisely: this formulation was studied in these people and produced this result.
